Results 81 to 90 of about 80,513 (156)
The interactions of cancer cells with components of the complement system are highly complex, leading to an outcome that is either favorable or detrimental to cancer cells. Currently, we perceive only the “tip of the iceberg” of these interactions.
Zvi Fishelson, Michael Kirschfink
doaj +1 more source
An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. [PDF]
Antibody-mediated rejection (AMR) of solid organ transplants (SOT) is characterized by damage triggered by donor-specific antibodies (DSA) binding donor Class I and II HLA (HLA-I and HLA-II) expressed on endothelial cells.
Fishbein, MC +7 more
core +1 more source
The surface of proteins is heterogeneous with sophisticated but precise hydrophobic and hydrophilic patches, which is essential for their diverse biological functions.
Andreozzi, P. +17 more
core +1 more source
Antibodies against complement-regulatory proteins on platelets in immune thrombocytopenia
In immune thrombocytopenia (ITP), antibodies reacting with platelet membrane glycoproteins (GP) mediate premature platelet cleavage, resulting in thrombocytopenia and therefore a risk of bleeding.
Ursula Unterberger +3 more
doaj +1 more source
Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets. [PDF]
Xie CB, Jane-Wit D, Pober JS.
europepmc +1 more source
Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization
The Gram-negative bacterium Klebsiella pneumoniae is an important human pathogen. Its treatment has been complicated by the emergence of multi-drug resistant strains. The human complement system is an important part of our innate immune response that can
Frerich M. Masson +6 more
doaj +1 more source
Modern biotherapy has been in use for some 30 years. The first types of biotherapy were nonspecific stimulators of the immune response, but advances in genetic engineering are allowing the mass production of pure biological products which are now being ...
Gallucci, Betty Bierut +1 more
core +1 more source
PRELP protein inhibits the formation of the complement membrane attack complex. [PDF]
Happonen KE +4 more
europepmc +2 more sources
Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman Primates. [PDF]
Skuk D, Tremblay JP.
europepmc +1 more source
Membrane attack complex in biliary atresia: new insight for etiopathogenesis
Purpose Biliary atresia (BA) is the most common cause of neonatal cholestasis (NC); nevertheless, there is a lack of an established etiology. Understanding etiopathogenesis opens the way to adjuvant medical therapy.
Mohamed Abdel-Salam El-Guindi +5 more
doaj +1 more source

